About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Arizona | 379 Studies

Clinical Trials Prostate CancerArizona

Prostate Cancer Clinical Trials in Arizona

Find 379 clinical trials for prostate cancer near Arizona. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 161-180 of 379 trials

CompletedSafety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate CancerThe study will evaluate if Leuprolide Mesylate is safe and effective in the treatment of subjects with prostate cancer, when administered as two injections twelve weeks apart.NCT03261999·Homewood, Alabama and 20 others CompletedZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA)This study is being carried out to see if ZD4054 (Zibotentan) is effective in treating prostate cancer and spread of cancer to the bone, and if so, how it compares with placebo…NCT00090363·Tucson, Arizona and 59 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedCJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene MutationsThis phase II trial tests how well abiraterone acetate/niraparib (CJNJ-67652000 \[niraparib/abiraterone acetate fixed-dose combination\]) and prednisone works in treating patients…NCT05689021·Scottsdale, Arizona and 2 others

CompletedS1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate CancerThe purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation therapy (ADT) + TAK-700…NCT01809691·Birmingham, Alabama and 559 others

CompletedAn Open-label Extension Study of PSMA ADC 2301 in mCRPCPSMA ADC 2301EXT is an open-label study to further assess the anti-tumor activity as measured by radiographic imaging and biomarkers, safety and tolerability of Prostate Specific…NCT02020135·Tucson, Arizona and 5 others

CompletedMitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)To determine the time to progression produced by the combination of Novantrone (mitoxantrone) and Erbitux (cetuximab) versus Novantrone alone in metastatic AIPC patients…NCT00661492·Phoenix, Arizona and 54 others

RecruitingImmunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer PatientsThis early phase I is to find out how common vitamin D insufficiency is among African American patients with a history of prostate cancer that has not spread to other parts of the…NCT05045066·Scottsdale, Arizona and 1 other

CompletedStudy of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate CancerThis study is being done to evaluate the safety and efficacy of atrasentan in men with non-metastatic hormone-refractory prostate cancer.NCT00036556·Homewood, Alabama and 233 others

TerminatedEffect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate CancerThe purpose of this study is to determine whether GTx 758 is effective in achieving and maintaining castrate testosterone levels in men with advanced prostate cancer.NCT01326312·Phoenix, Arizona and 35 others

Recruiting4-aminopyridine Treatment for Nerve InjuryTo evaluate the role of 4-aminopyridine (4-AP) on the course of recovery after peripheral nerve traction and/or crush injury.NCT03701581·Tucson, Arizona and 1 other

CompletedA Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011)Researchers have designed a study medicine called MK-5684 as a new way to treat prostate cancer.NCT06554639·Tempe, Arizona

CompletedMEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate CancerThe primary objectives of this study are: 1.NCT00072930·Hoover, Alabama and 56 others

CompletedPemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsRATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells of by stopping them from dividing.NCT01172028·Tucson, Arizona

CompletedIsoflavones & Lycopene in Localized Prostate Ca:Prior to Radical ProstatectomyRATIONALE: Eating a diet rich in isoflavones, compounds found in soy foods, or lycopene, a substance found in tomatoes, may keep prostate cancer from growing.NCT00042731·Phoenix, Arizona and 4 others

TerminatedPositive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate CancerThe primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant…NCT01981109·Anchorage, Alaska and 57 others

RecruitingREGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell CarcinomaThis study is researching a new drug called REGN15505 when used alone or in combination with cemiplimab or in combination with REGN4336 in adult patients with mCRPC and ccRCC.NCT07594106·Goodyear, Arizona and 5 others

UnknownEnzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerThis randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone, and prednisone in treating patients with castration-resistant…NCT01949337·Birmingham, Alabama and 538 others

CompletedStudy of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate CancerThis study is being conducted to assess the safety and tolerability of relugolix with other agents approved for use in combination with androgen deprivation therapy (ADT) for a…NCT04666129·Tucson, Arizona and 15 others

TerminatedMaintaining Suppression of Testosterone With Transdermal Estradiol GelThe objective of this clinical study is to evaluate the safety and efficacy of three different doses of BHR-200 (0.36% transdermal estradiol gel) compared to placebo for the…NCT02349386·Tucson, Arizona and 11 others

CompletedAndrogen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen ablation therapy may stop the adrenal glands from making androgens.NCT00309985·Anchorage, Alaska and 342 others

PreviousPage 9 of 19Next

Other Conditions in Arizona

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma